ghk-cu copper peptide scientific studies GHK-Cu Copper Peptides: 50 Years

3rd-Party Lab Tested Every batch is independently tested for purity and quality

We stay devoted to simple formulas that work while continuously innovating new solutions

Dysesthesia The TRIUMPH-4 trial data revealed a notable safety signal: dysesthesia (abnormal sensations like tingling, burning, or numbness) was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose of retatrutide

10.1136/gut.2005.085373 321

Shaking creates foam, introduces air throughout the solution, and generates mechanical stress that can denature the peptide

Some researchers prefer different concentrations for various reasons